Literature DB >> 19835963

Context-dependent perturbation of neural systems in transgenic mice expressing a cytosolic prion protein.

Henryk Faas1, Walker S Jackson, Andrew W Borkowski, Xinhe Wang, Jiyan Ma, Susan Lindquist, Alan Jasanoff.   

Abstract

We analyzed the relationship between pathogenic protein expression and perturbations to brain anatomy and physiology in a genetic model of prion disease. In this model, the mouse line 1D4, neuropathology is promoted by accumulation of a cytosolic form of the prion protein (cyPrP). CyPrP distribution was determined and compared with anatomical magnetic resonance imaging (MRI) data, a form of functional MRI based on manganese labeling, and immediate early gene mapping with an antibody to c-Fos. Significant discrepancies between 1D4 and control mice became apparent well in advance of overt behavioral pathology in the mutant mice. Alterations to brain structure and function in the mutants varied among brain regions, however, and differed strikingly even among regions with the highest levels of cyPrP expression. In the cerebellum, gross neurodegeneration was accompanied by increased Mn(2+)-enhanced MRI signal, raising the possibility that compensatory mechanisms act to preserve cerebellar function in the face of massive atrophy. In the hippocampus of 1D4 mice, no significant structural alterations were observed, but both Mn(2+)-enhanced MRI and c-Fos data indicated perturbations to neurophysiology. In the neocortex, there were no clear neural activity differences between 1D4 and control animals, but mutant mice showed significant reduction in cortical thickness. Our finding that distinct combinations of anatomical and functional abnormalities accompanied cyPrP overexpression in different parts of the brain indicates the importance of context in conditioning effects of protein pathogens, and exemplifies the notion that neurodegenerative phenotypes extend beyond cell death and the immediate consequences of atrophy for particular neural systems. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835963      PMCID: PMC7605312          DOI: 10.1016/j.neuroimage.2009.10.009

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  48 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

3.  Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.

Authors:  Sang-Wook Kang; Neena S Rane; Soo Jung Kim; Jennifer L Garrison; Jack Taunton; Ramanujan S Hegde
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

4.  Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration.

Authors:  Neena S Rane; Sang-Wook Kang; Oishee Chakrabarti; Lionel Feigenbaum; Ramanujan S Hegde
Journal:  Dev Cell       Date:  2008-09       Impact factor: 12.270

5.  Scrapie infection of transgenic mice leads to network and intrinsic dysfunction of cortical and hippocampal neurones.

Authors:  J G Jefferys; R M Empson; M A Whittington; S B Prusiner
Journal:  Neurobiol Dis       Date:  1994-11       Impact factor: 5.996

6.  Manganese-enhanced MRI reveals structural and functional changes in the cortex of Bassoon mutant mice.

Authors:  Frank Angenstein; Heiko G Niessen; Jürgen Goldschmidt; Holger Lison; Wilko D Altrock; Eckart D Gundelfinger; Henning Scheich
Journal:  Cereb Cortex       Date:  2006-02-01       Impact factor: 5.357

7.  Cholinergic involvement in the cortical and hippocampal Fos expression induced in the rat by placement in a novel environment.

Authors:  David Wirtshafter
Journal:  Brain Res       Date:  2005-07-27       Impact factor: 3.252

8.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

Review 9.  alpha-Synucleinopathy models and human neuropathology: similarities and differences.

Authors:  Philipp J Kahle
Journal:  Acta Neuropathol       Date:  2007-10-12       Impact factor: 17.088

10.  Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein.

Authors:  Andrea Orsi; Luana Fioriti; Roberto Chiesa; Roberto Sitia
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

View more
  9 in total

1.  Potential of N-acetylated-para-aminosalicylic acid to accelerate manganese enhancement decline for long-term MEMRI in rodent brain.

Authors:  Aditya N Bade; Biyun Zhou; JoEllyn McMillan; Prabagaran Narayanasamy; Ram Veerubhotla; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  J Neurosci Methods       Date:  2015-05-22       Impact factor: 2.390

2.  Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases.

Authors:  Walker S Jackson; Andrew W Borkowski; Nicki E Watson; Oliver D King; Henryk Faas; Alan Jasanoff; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

3.  The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.

Authors:  Tiziana Sonati; Regina R Reimann; Jeppe Falsig; Pravas Kumar Baral; Tracy O'Connor; Simone Hornemann; Sine Yaganoglu; Bei Li; Uli S Herrmann; Barbara Wieland; Mridula Swayampakula; Muhammad Hafizur Rahman; Dipankar Das; Nat Kav; Roland Riek; Pawel P Liberski; Michael N G James; Adriano Aguzzi
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

4.  Cell type-specific neuroprotective activity of untranslocated prion protein.

Authors:  Elena Restelli; Luana Fioriti; Susanna Mantovani; Simona Airaghi; Gianluigi Forloni; Roberto Chiesa
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

Review 5.  Interactions of prion protein with intracellular proteins: so many partners and no consequences?

Authors:  Krzysztof Nieznanski
Journal:  Cell Mol Neurobiol       Date:  2009-12-30       Impact factor: 5.046

6.  Translation of the prion protein mRNA is robust in astrocytes but does not amplify during reactive astrocytosis in the mouse brain.

Authors:  Walker S Jackson; Clemens Krost; Andrew W Borkowski; Lech Kaczmarczyk
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 7.  Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein.

Authors:  Walker S Jackson
Journal:  Dis Model Mech       Date:  2014-01       Impact factor: 5.758

8.  Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2.

Authors:  Emiliano Zamponi; Fiamma Buratti; Gabriel Cataldi; Hector Hugo Caicedo; Yuyu Song; Lisa M Jungbauer; Mary J LaDu; Mariano Bisbal; Alfredo Lorenzo; Jiyan Ma; Pablo R Helguera; Gerardo A Morfini; Scott T Brady; Gustavo F Pigino
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

9.  Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice.

Authors:  Walker S Jackson; Andrew W Borkowski; Henryk Faas; Andrew D Steele; Oliver D King; Nicki Watson; Alan Jasanoff; Susan Lindquist
Journal:  Neuron       Date:  2009-08-27       Impact factor: 17.173

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.